Literature DB >> 22722879

Calcineurin/NFATc1 pathway contributes to cell proliferation in hepatocellular carcinoma.

Shuhuai Wang1, Xinmei Kang, Shouqiang Cao, Hui Cheng, Di Wang, Jingshu Geng.   

Abstract

BACKGROUND AND AIMS: The nuclear factor of the activated T cell (NFAT) family was primarily recognized for its central role in T lymphocyte activation. Recent evidence showed that NFAT isoforms participate in the regulation of genes related to cell proliferation and differentiation in epithelial malignancies. Here, we investigated the expression and activation of the calcineurin/NFAT transcription pathway and its role in hepatocellular carcinoma (HCC) proliferation.
METHODS: Expression of NFATc1 and calcineurin proteins was examined by immunohistochemical analyses in 76 human HCC samples. The cellular NFAT activation and distribution in HepG2 cells were analyzed by immunofluorescence and western blot analyses. After NFATc1 expression was knocked down by NFATc1-specific siRNA, we analyzed its implications in cell cycle progression and growth by MTT and flow cytometry. The impact of calcineurin/NFAT signaling on protein expression of c-myc and cox-2 were performed by western blot analyses.
RESULTS: NFATc1 is significantly overexpressed in HCC. The regulation of calcineurin activity by ionomycin or cyclosporin A caused rapid nuclear import or export of NFATc1 in HepG2 cells. NFATc1 knock-down led to a significant reduction in proliferation rates and cell cycle arrest at G1 phase. The expression of c-myc and cox-2 was decreased in the NFATc1 knock-down HepG2 cells. Ionomycin increased c-myc and cox-2 expression in HepG2 cells, but not in siNFATc1 HepG2 cells.
CONCLUSION: The calcineurin/NFATc1 signal is overexpressed and active in HCC. It may enhance the proliferative potential of HepG2 cells through transcriptional activation of the c-myc and cox-2 oncogenes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722879     DOI: 10.1007/s10620-012-2255-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

Review 2.  NFAT proteins: key regulators of T-cell development and function.

Authors:  Fernando Macian
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

Review 3.  New drugs for the treatment of hepatocellular carcinoma.

Authors:  Eveline Boucher; Alejandro Forner; Maria Reig; Jordi Bruix
Journal:  Liver Int       Date:  2009-01       Impact factor: 5.828

Review 4.  Cyclooxygenases in hepatocellular carcinoma.

Authors:  Melchiorre Cervello; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 5.  Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.

Authors:  Jennifer L Giglia; Scott J Antonia; Lawrence B Berk; Salvador Bruno; Sophie Dessureault; Steven E Finkelstein
Journal:  Cancer Control       Date:  2010-04       Impact factor: 3.302

6.  Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation.

Authors:  Garima Singh; Shiv K Singh; Alexander König; Kristina Reutlinger; Monica D Nye; Tillman Adhikary; Martin Eilers; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

7.  Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation.

Authors:  Shih-Chu Kao; Hai Wu; Jianming Xie; Ching-Pin Chang; Jeffrey A Ranish; Isabella A Graef; Gerald R Crabtree
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

8.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

Review 9.  Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.

Authors:  Andreas H Mahnken; Philipp Bruners; Rolf W Günther
Journal:  Dig Dis       Date:  2009-06-22       Impact factor: 2.404

Review 10.  HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.

Authors:  John D Gordan; Craig B Thompson; M Celeste Simon
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

View more
  20 in total

1.  Betacellulin ameliorates hyperglycemia in obese diabetic db/db mice.

Authors:  Yoon Sin Oh; Seungjin Shin; Hui Ying Li; Eun-Young Park; Song Mi Lee; Cheol Soo Choi; Yong Lim; Hye Seung Jung; Hee-Sook Jun
Journal:  J Mol Med (Berl)       Date:  2015-06-14       Impact factor: 4.599

Review 2.  Mechanisms of cholangiocyte responses to injury.

Authors:  Keisaku Sato; Fanyin Meng; Thao Giang; Shannon Glaser; Gianfranco Alpini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-23       Impact factor: 5.187

Review 3.  Calcineurin in development and disease.

Authors:  Lei Chen; Min Song; Chunyan Yao
Journal:  Genes Dis       Date:  2021-03-15

4.  Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Authors:  Saurav Singh; Alexander Grabner; Christopher Yanucil; Karla Schramm; Brian Czaya; Stefanie Krick; Mark J Czaja; Rene Bartz; Reimar Abraham; Giovana S Di Marco; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Kidney Int       Date:  2016-07-22       Impact factor: 10.612

5.  NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.

Authors:  Wenwen Xu; Junjie Gu; Qingling Ren; Yanqiu Shi; Qinhua Xia; Jing Wang; Suli Wang; Yingchun Wang; Jinhua Wang
Journal:  Tumour Biol       Date:  2015-10-26

6.  Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.

Authors:  Takashi Kawahara; Eiji Kashiwagi; Hiroki Ide; Yi Li; Yichun Zheng; Yurina Miyamoto; George J Netto; Hitoshi Ishiguro; Hiroshi Miyamoto
Journal:  Oncotarget       Date:  2015-01-30

7.  NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract.

Authors:  Takashi Kawahara; Satoshi Inoue; Kazutoshi Fujita; Taichi Mizushima; Hiroki Ide; Seiji Yamaguchi; Hiroaki Fushimi; Norio Nonomura; Hiroshi Miyamoto
Journal:  Transl Oncol       Date:  2017-03-19       Impact factor: 4.243

8.  Akirin2 regulates proliferation and differentiation of porcine skeletal muscle satellite cells via ERK1/2 and NFATc1 signaling pathways.

Authors:  Xiaoling Chen; Yanliu Luo; Zhiqing Huang; Gang Jia; Guangmang Liu; Hua Zhao
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

9.  NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide.

Authors:  Xiuli Zhang; Ting Kang; Lian Zhang; Yingying Tong; Wenping Ding; Siyu Chen
Journal:  Oncotarget       Date:  2017-04-18

10.  Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.

Authors:  Jin Ma; Rao Du; Yan Huang; Wen Zhong; Huan Gui; Chenmei Mao; Xiudao Song; Jun Lu
Journal:  Pathol Oncol Res       Date:  2021-04-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.